Cancer Medicine : Cancer is a very dangerous disease. Its treatment is possible only after its detection in the beginning. Its treatment is very expensive. Not everyone can afford to get cancer treatment. Many of its medicines are imported from abroad, due to which its price is very high.
Keeping this in mind, the government has abolished the custom duty on three cancer medicines. After which the price of these medicines can be reduced by 15-20%. In such a situation, let us know what kind of cancer the three medicines on which the custom duty has been reduced are used for. Certainly, these medicines becoming cheaper will definitely have an impact on cancer treatment.
From which three medicines custom duty was removed
1. Trastuzumab Deruxtecan
2. Osimertinib
3. Durvalumab
trastuzumab deruxtecan
This drug is used in the treatment of breast cancer. Apart from this, it is also used in stomach cancer. According to statistics, every year about 14 lakh new cases of cancer are reported in the country, of which the highest number of cases are of breast cancer. The price of breast cancer drug trastuzumab deruxtecan is up to Rs 58,000.
osimertinib
Osimartinib is a drug used in lung cancer. This drug is also quite expensive. It is a monoclonal antibody. This medicine is available in India from AstraZeneca company. It has 2 variants, which cost around Rs 1.50 lakh. This drug is available in the market under the name Tagrisso.
Durvalumab
Durvalumab is used to treat urinary bladder cancer. This drug is also used in lung cancer. In India, AstraZeneca is the company that manufactures this drug. It also has two variants. Its price ranges from Rs 45,000 to Rs 1.90 lakh. This drug is available in the market under the name Imfinzi.
Disclaimer: Some of the information given in the news is based on media reports. Before implementing any suggestion, please consult the concerned expert.
Check out below Health Tools-
Calculate Your Body Mass Index (BMI)
